Certara vs Pharmaron

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/certara/pharmaron

Category	Certara	Pharmaron
Listed site	cro	both
Summary	Certara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.	Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Services	Biostatistics & Statistical Programming Data Management & eClinical Regulatory Affairs Medical Writing Computational & In-Silico Drug Discovery Translational Research Target Identification & Validation High-Throughput Screening Medicinal Chemistry In Vitro Pharmacology In Vitro ADME / DMPK Safety Pharmacology Genetic Toxicology Discovery Research In Vivo Efficacy Models In Vivo PK / PD Studies GLP Toxicology Preclinical In Vitro Studies Preclinical In Vivo Studies Bioanalysis LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Phase I Clinical Trials Biomarker Assays Phase II Clinical Trials Phase III Clinical Trials Clinical Operations Phase IV / Post-Marketing US FDA Regulatory Strategy US FDA Regulatory Strategy EU EMA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy China NMPA Regulatory Strategy Clinical Trial Services	Medicinal Chemistry Computational & In-Silico Drug Discovery High-Throughput Screening Target Identification & Validation In Vitro Pharmacology In Vitro ADME / DMPK Safety Pharmacology Genetic Toxicology GLP Toxicology In Vivo PK / PD Studies In Vivo Efficacy Models Preclinical In Vivo Studies Preclinical In Vitro Studies Bioanalysis LC-MS Bioanalysis (Small Molecule) Ligand-Binding Bioanalysis (Large Molecule) Immunogenicity Assays (ADA / NAb) Biomarker Assays Flow Cytometry Services Analytical Method Development & Validation ICH Stability Studies CMC Analytical Development Process Development Formulation Development API Synthesis & Manufacturing Small Molecule Development & Manufacturing Flow Chemistry & Continuous Manufacturing HPAPI Manufacturing (High-Potency) Controlled Substance Manufacturing Cell-Line Development Recombinant Protein Manufacturing Monoclonal Antibody (mAb) Manufacturing Biologics Development & Manufacturing Upstream Processing Downstream Processing Microbial Fermentation ADC (Antibody-Drug Conjugate) Manufacturing ADC Payload & Linker Synthesis Bioconjugation Services Viral Vector Manufacturing AAV Manufacturing Lentiviral Vector Manufacturing Cell Therapy Manufacturing Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing mRNA Manufacturing Lipid Nanoparticle (LNP) Formulation Oligonucleotide Manufacturing Peptide Manufacturing Vaccine Manufacturing Sterile Fill-Finish & Aseptic Manufacturing Vial Filling Prefilled Syringe (PFS) Filling Cartridge Filling Lyophilization (Freeze Drying) Oral Solid Dosage Manufacturing Topical & Semi-Solid Manufacturing Inhalation & Nasal Dosage Manufacturing Ophthalmic Manufacturing Technology Transfer Quality Control Testing Stability Testing & Storage Extractables & Leachables Studies Secondary Packaging & Labeling Serialization & Track-and-Trace Cold-Chain Storage & Logistics Combination Product Assembly & Final Packaging CMC Regulatory Submission Support Regulatory Affairs US FDA Regulatory Strategy EU EMA Regulatory Strategy Japan PMDA Regulatory Strategy China NMPA Regulatory Strategy Clinical Trial Services Phase I Clinical Trials Phase II Clinical Trials Phase III Clinical Trials Phase IV / Post-Marketing Clinical Operations Data Management & eClinical Biostatistics & Statistical Programming Pharmacovigilance & Drug Safety Medical Writing Central Laboratory Services Clinical Imaging Core Lab Translational Research Companion Diagnostics Development Microbiology Services Virology Services Immunology & Inflammation Services Oncology Specialty Services CNS Specialty Services Cardiovascular & Metabolic Specialty Services Pathology & Histology Services Proteomics Services Genomics & Sequencing Services Bioinformatics & Data Science Device & Combination Product Services Discovery Research
Modalities	Small Molecule Small Molecule Biologics (Monoclonal Antibodies) Biologics (Monoclonal Antibodies) Biologics (Other) Biologics (Other) Peptide Peptide Oligonucleotide Oligonucleotide mRNA mRNA Antibody-Drug Conjugate (ADC) Antibody-Drug Conjugate (ADC) Gene Therapy Gene Therapy Cell Therapy Cell Therapy Vaccine Vaccine	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Antibody-Drug Conjugate (ADC) Oligonucleotide mRNA Cell Therapy Gene Therapy Vaccine Peptide Radiopharmaceutical Microbiome Therapeutic AAV / Viral Vector Platform Synthetic Biology
Indications	Oncology Rare Disease Immunology Immunology Neurology Neurology Psychiatry Metabolic Metabolic Cardiovascular Cardiovascular Infectious Disease Infectious Disease Respiratory Respiratory Dermatology Dermatology Ophthalmology Ophthalmology Gastroenterology Gastroenterology Nephrology Nephrology Women's Health Women's Health	Oncology Immunology Neurology Psychiatry Metabolic Cardiovascular Infectious Disease Rare Disease Respiratory Dermatology Ophthalmology Gastroenterology Nephrology Women's Health
Locations	Global network Global presence, 30 countries Global presence, Multiple, 30 countries, Global Global presence, Multiple, 30+ countries Global presence, Multiple, 30 countries, International Headquarters, Radnor, Pennsylvania, United States Global presence, 30 countries Global presence, 30+ countries	Beijing Headquarters, Beijing, Beijing, China Beijing TSP, Beijing, Beijing, China Beijing Campus II, Beijing, Beijing, China Beijing Campus III, Beijing, Beijing, China Xi'an Chemistry, Xi'an, Shaanxi, China Tianjin Chemical Manufacturing, Tianjin, Tianjin, China Hangzhou AI-Enabled Patient Management, Hangzhou, Zhejiang, China Shanghai Clinical Development, Shanghai, Shanghai, China Shaoxing Commercial API Manufacturing, Shaoxing, Zhejiang, China Ningbo Campus I, Ningbo, Zhejiang, China Ningbo Campus II, Ningbo, Zhejiang, China Ningbo Campus III, Ningbo, Zhejiang, China Nanjing Clinical R&D, Nanjing, Jiangsu, China Qingdao Chemistry, Qingdao, Shandong, China Wuxi Structural Biology & Protein Science, Wuxi, Jiangsu, China Singapore Drug Product Manufacturing, Singapore, Singapore, Singapore Rushden Radiolabelled Chemistry & Metabolism, Rushden, Northamptonshire, United Kingdom Hoddesdon Discovery & Early Development, Hoddesdon, Hertfordshire, United Kingdom Liverpool Gene Therapy CDMO, Liverpool, Merseyside, United Kingdom Cardiff Radiolabelled Chemistry, Cardiff, Wales, United Kingdom Cramlington Commercial API Manufacturing, Cramlington, Northumberland, United Kingdom Louisville Logistics, Louisville, Kentucky, United States Coventry Commercial API Manufacturing, Coventry, West Midlands, United Kingdom San Diego Animal Models, Toxicology, Ocular, Medical Devices, San Diego, California, United States Germantown Clinical Bioanalytical, Germantown, Maryland, United States Boston Biologics, CGT, Boston, Massachusetts, United States Baltimore Clinical Research, Baltimore, Maryland, United States Exton DMPK, Cell and Gene Therapy, Exton, Pennsylvania, United States Headquarters, Beijing, China Operations, China, China Operations, United States, United States Operations, United Kingdom, United Kingdom
Certifications	Data not yet provided.	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.